NCT06408363

Brief Summary

Middle ear barotrauma represents the predominant complication associated with hyperbaric oxygen therapy, manifesting symptoms ranging from otalgia to tympanic membrane perforation. Several pressurization protocols have been proposed to reduce the incidence of this trauma, but barotrauma is still the main cause of poor adherence to hyperbaric therapy. Therefore, this study aims to evaluate the effectiveness of serial tubal opening maneuvers to prevent barotrauma in patients undergoing treatment in a hyperbaric chamber.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
May 2023Dec 2026

Study Start

First participant enrolled

May 1, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 10, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 9, 2026

Status Verified

June 1, 2025

Enrollment Period

3.6 years

First QC Date

April 18, 2024

Last Update Submit

February 5, 2026

Conditions

Keywords

BarotraumaTympanic Membrane PerforationEustachian TubeHyperbaric Oxygenation

Outcome Measures

Primary Outcomes (1)

  • Incidence Reduction of Barotrauma

    Patients performing Eustachian tube opening maneuvers will experience a lower incidence of barotrauma

    Until completion of the study, on average 10 months

Study Arms (2)

Maneuver group

EXPERIMENTAL

Patients in the experimental group will receive detailed training and guidance on pressure equalization techniques and barotrauma prevention measures before undergoing treatment in a hyperbaric chamber. The specific maneuvers to be implemented are outlined below: Toynbee Maneuver: This maneuver involves swallowing with both the mouth and nose closed, thereby reducing the pressure in the nasopharynx and tympanic cavity. Unilateral Passive Valsalva Maneuver: This technique involves occluding one external nasal valve while performing a Valsalva maneuver on the opposite side. These maneuvers will be performed continuously during the compression phase of the hyperbaric chamber, every 30 minutes after reaching the desired pressurization level, and continuously during the decompression phase.

Behavioral: Maneuver group

Standard treatment

NO INTERVENTION

Patients will receive the standard instructions for the hyperbaric chamber without specific guidance on performing equalization maneuvers.

Interventions

Maneuver groupBEHAVIORAL

These maneuvers for Eustachian tube opening will be performed continuously during the compression phase of the hyperbaric chamber, every 30 minutes after reaching the desired pressurization level, and continuously during the decompression phase.

Maneuver group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient undergoing the first hyperbaric session.
  • Understanding and properly carrying out equalization maneuvers

You may not qualify if:

  • Patients who did not understand the equalization maneuvers
  • Patients with specific contraindications to hyperbaric therapy
  • Patients with acute middle ear or tympanic membrane disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Felicio Rocho

Belo Horizonte, Minas Gerais, 30110-934, Brazil

RECRUITING

MeSH Terms

Conditions

Tympanic Membrane PerforationBarotrauma

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesWounds and Injuries

Central Study Contacts

Alan Rodrigues de Almeida Paiva, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 18, 2024

First Posted

May 10, 2024

Study Start

May 1, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 9, 2026

Record last verified: 2025-06

Locations